Boryung and Korea Organon to jointly market Atojet in South Korea
AI Summary- Boryung and Korea Organon signed an agreement to jointly sell and market Atojet in South Korea.
- Atojet is offered in four dosage types and has been distributed domestically since last month.
- Boryung plans to provide medical professionals with dyslipidemia treatment information.